TrialBMC cancer2024

Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting.

Cong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.